Robert Iannone, EVP and Global Head of R&D and CMO at Jazz Pharmaceuticals plc ($JAZZ), sold shares on the open market once in the last 365 days for a total of $1.2 million. His most recent sale occurred on November 17, 2025. These sales rank 4509th among 11,678 individual insiders, where the average is $8.6 million across about 6.4 transactions per insider. Iannone made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | F | Ordinary Shares | 6209 | $188.69 | 88,871.0000 | 61,606,000 | 6.53% | 0.01% |
| Feb. 26, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | A | Ordinary Shares | 14822 | $0.00 | 95,080.0000 | 61,606,000 | 18.47% | 0.02% |
| Jan. 16, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | A | Ordinary Shares | 11699 | $0.00 | 84,398.0000 | 61,606,000 | 16.09% | 0.02% |
| Jan. 16, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | F | Ordinary Shares | 4140 | $171.16 | 80,258.0000 | 61,606,000 | 4.91% | 0.01% |
| Nov. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | S | Ordinary Shares | 7159 | $168.26 | 72,628.0000 | 61,606,000 | 8.97% | 0.01% |
| March 10, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | S | Ordinary Shares | 2403 | $138.41 | 79,621.0000 | 66,007,000 | 2.93% | 0.00% |
| March 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | S | Ordinary Shares | 1548 | $140.00 | 82,024.0000 | 66,007,000 | 1.85% | 0.00% |
| March 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | S | Ordinary Shares | 5532 | $138.21 | 83,572.0000 | 66,007,000 | 6.21% | 0.01% |
| March 5, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D & CMO | D | Ordinary Shares | 5239 | $138.95 | 89,104.0000 | 66,007,000 | 5.55% | 0.01% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, G R&D and CMO | A | Ordinary Shares | 17718 | $0.00 | 85,484.0000 | 66,007,000 | 26.15% | 0.03% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, G R&D and CMO | A | Ordinary Shares | 8859 | $0.00 | 94,343.0000 | 66,007,000 | 10.36% | 0.01% |
| Jan. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, G R&D and CMO | A | Ordinary Shares | 7506 | $0.00 | 69,947.0000 | 66,007,000 | 12.02% | 0.01% |
| Jan. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, G R&D and CMO | F | Ordinary Shares | 2181 | $122.62 | 67,766.0000 | 66,007,000 | 3.12% | 0.00% |
| June 11, 2024 | iTeos Therapeutics, Inc. | $ITOS | Iannone Robert | Not found | A | Stock Option (Right to Buy) | 24200 | $0.00 | 24,200.0000 | 0 | 9999.99% | 0.00% |
| March 5, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D | F | Ordinary Shares | 4294 | $117.53 | 62,226.0000 | 72,066,000 | 6.46% | 0.01% |
| March 1, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D | A | Ordinary Shares | 16928 | $0.00 | 66,520.0000 | 72,066,000 | 34.13% | 0.02% |
| Jan. 17, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D | F | Ordinary Shares | 1730 | $119.13 | 49,592.0000 | 72,066,000 | 3.37% | 0.00% |
| Jan. 17, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of R&D | A | Ordinary Shares | 5970 | $0.00 | 51,322.0000 | 72,066,000 | 13.16% | 0.01% |
| June 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of Research a | D | Ordinary Shares | 1311 | $129.73 | 45,315.0000 | 62,539,000 | 2.81% | 0.00% |
| March 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of Research a | A | Ordinary Shares | 12447 | $0.00 | 48,763.0000 | 62,539,000 | 34.27% | 0.02% |
| March 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Iannone Robert | EVP, Global Head of Research a | F | Ordinary Shares | 2274 | $142.78 | 46,489.0000 | 62,539,000 | 4.66% | 0.00% |